Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 14 of 14 for “"Vildagliptin"”.
-
Η επίδραση των αναστολέων της διπεπτυδυλπεπτιδάσης 4 στη λειτουργία του ενδοθηλίου και στην ελαστικότητα της αορτής σε διαβητικούς τύπου 2
… of dipeptidyl-peptidase-4 (DPP-4) inhibitor, vildagliptin, on endothelial function and arterial stiffness (AS) in patients with type 2 diabetes (Τ2DM). Sixty-four drug-naive diabetic patients, with inadequate glycemic control, participated in this randomized, open-label study. Half of the …
-
DPP4 baltymo įtakos kolorektalinio vėžio ląstelių epitelinei-mezenchiminei tranzicijai ir atsparumo chemoterapiniams vaistams tyrimai /
… lines. Also, it was shown, that treatment with vildagliptin, an inhibitor of DPP4 catalytic activity, barely has no effect on resistance to anticancer drugs in HCT-P, HCT-P iDPP4, HCT-Oxa and HCT-Fu cell lines. However, treatment with vildagliptin increased E-cadherin protein levels in HCT-P …
-
Glucagon Counter-Regulation to Hypoglycemia During Incretin-Based Therapy
… were examined. In all, the four studies examined vildagliptin (DPP-4 inhibition) + insulin in T1DM (study 1), vildagliptin + insulin (±oral medication) in T2DM (study 2), lixisenatide (GLP-1 RA) + basal insulin + metformin in T2DM (study 3) and sitagliptin (DPP-4 inhibition) + metformin in elderly …
-
Precision Medicine in Diabetes Mellitus among Māori and Pacific Peoples in Aotearoa New Zealand
… gain with pioglitazone treatment relative to vildagliptin. This finding requires validation before the practical applications of genotype-informed diabetes care can be assessed further. The heritability of glycaemic response to metformin and the influence of the SLC22A3 rs8187715 variant on …
-
Insight into appetite and blood glucose regulation in anorexia nervosa and health: Examining gastrointestinal changes in starvation and with short-term refeeding
… IV (DPP-IV). We utilised the DPP-IV inhibitor, vildagliptin, to modulate the effects of intraduodenal (ID) fat, examining downstream effects on glycemia, postprandial triglycerides, energy intake and energy expenditure. Both gastric emptying and GI hormone secretion are sensitive to changes in …
-
The insulinotropic effect of the enteral hormone glucagon-like peptide-1 in the portal and systemic circulation of rats
… Furthermore, the failure of the DPP-IV inhibitor vildagliptin to protect the majority of GLP-1 infused into the portal vein from degradation does not support the concept that this drug class acts by augmenting GLP-1 levels in the circulation. Other alternatives to an endocrine model of GLP-1 …
-
Avaliação das concentrações plasmáticas e teciduais de vildagliptina em ratos diabéticos e sadios através de microdiálise
Objetivo: Avaliar a farmacocinética da vildagliptina em animais sadios e diabéticos, através da análise dos níveis plasmáticos totais e livres teciduais, empregando-se a técnica de microdiálise. Metodologia: A doença foi induzida nos animais através da administração de 42mg/kg de aloxano através da …
-
Comparison of chickpea varieties, optimization of hydrolysates production, peptide identification and evaluation of biomarkers for type 2 diabetes in the application of a value-added tortilla.
… of -5.8 kcal/mol for FDLPAL in comparison with vildagliptin (-6.2 kcal/mol). Physical analysis of fortified tortillas showed changes in color (∆E) for both white and blue tortillas at all fortification levels compared to the control. In fresh tortillas, moisture content was higher for the 10% …
-
Estudo de biotransformação de fármacos através de Cunninghamella elegans ATCC 9245
… de biotransformação dos fármacos linagliptina, vildagliptina, ticagrelor, rivaroxabana e metronidazol utilizando o fungo filamentoso Cunninghamella elegans ATCC 9245. Para o monitoramento do processo de biotransformação deste estudo, amostras de biotransformação e de controle de degradação do …
-
Desenvolvimento de métodos analíticos e avaliação da toxicidade in vitro de impurezas orgânicas da sitaglipina e vildagliptina
… medicamentos. O fostato de sitagliptina (STG) e vildagliptina (VLG), liberados para uso clínico no Brasil em 2006 e 2007, respectivamente, são utilizados para o tratamento do diabetes mellitus tipo 2. Na literatura pesquisada não foram encontrados relatos referentes à determinação quantitativa de …
-
Applications of Clinical Lipidomics to Metabolic Diseases: Methodology and Implications
Atherosclerosis is a leading cause of death and morbidity worldwide. It is driven by the persistent infiltration of lipid-carrying lipoproteins into the wall of large elastic arteries, where immune-cell driven inflammation drives further accumulation. This culminates in the development of lipidic …
-
Desenvolvimento e validação de métodos analíticos para determinação de vildagliptina em comprimidos
… caracterização e determinação quantitativa de vildagliptina (VLG) na forma farmacêutica comprimidos, assim como determinar a cinética de degradação do fármaco em condição de estresse. Métodos: método indicativo de estabilidade por cromatografia líquida de alta eficiência com detecção …
-
Vildagliptina e associação com metformina : desenvolvimento de metodologia analítica, ensaio de dissolução e estudo da estabilidade
A vildagliptina (VLG) e o cloridrato de metformina (MET) são fármacos utilizados no tratamento da diabetes mellitus tipo 2. Esses fármacos podem ser utilizados como monoterapia ou em associação como terapia complementar. A análise de fármacos dentro da área do controle de qualidade é essencial para …